Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Anne-Marie Duliege


  • Chief Medical Officer at Rigel Pharmaceuticals Inc (RIGL), 2017-07-07
  • Evp, Chief Of Strategic Dev. at Chemocentryx Inc. (CCXI), 2014-11-21
  • Chief Medical Officer at Affymax Inc (AFFY), 2013-02-01
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RIGL $2.69 5,000 Officer 0 2017-07-05 Filing
RIGL $2.41 5,000 Officer 0 2017-01-03 Filing
CCXI $4.71 4,970 Officer 0 2014-11-18 Filing
AFFY $22.90 1,056 Officer 23,125 2012-11-01 Filing
AFFY $24.00 9,704 Officer 23,125 2012-10-10 Filing